Your browser doesn't support javascript.
loading
A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.
Kakuta, Yoichi; Kawai, Yosuke; Naito, Takeo; Hirano, Atsushi; Umeno, Junji; Fuyuno, Yuta; Liu, Zhenqiu; Li, Dalin; Nakano, Takeru; Izumiyama, Yasuhiro; Ichikawa, Ryo; Okamoto, Daisuke; Nagai, Hiroshi; Matsumoto, Shin; Yamamoto, Katsutoshi; Yokoyama, Naonobu; Chiba, Hirofumi; Shimoyama, Yusuke; Onodera, Motoyuki; Moroi, Rintaro; Kuroha, Masatake; Kanazawa, Yoshitake; Kimura, Tomoya; Shiga, Hisashi; Endo, Katsuya; Negoro, Kenichi; Yasuda, Jun; Esaki, Motohiro; Tokunaga, Katsushi; Nakamura, Minoru; Matsumoto, Takayuki; McGovern, Dermot P B; Nagasaki, Masao; Kinouchi, Yoshitaka; Shimosegawa, Tooru; Masamune, Atsushi.
Affiliation
  • Kakuta Y; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kawai Y; Tohoku Medical Megabank Organisation, Tohoku University, Sendai, Japan.
  • Naito T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Hirano A; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Umeno J; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Fuyuno Y; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Liu Z; F. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
  • Li D; F. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
  • Nakano T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Izumiyama Y; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Ichikawa R; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Okamoto D; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Nagai H; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Matsumoto S; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Yamamoto K; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Yokoyama N; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Chiba H; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Shimoyama Y; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Onodera M; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Moroi R; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kuroha M; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kanazawa Y; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Kimura T; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Shiga H; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Endo K; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Negoro K; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Yasuda J; Tohoku Medical Megabank Organisation, Tohoku University, Sendai, Japan.
  • Esaki M; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tokunaga K; Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Nakamura M; Clinical Research Centre, National Hospital Organisation [NHO] Nagasaki Medical Centre, Omura, Japan.
  • Matsumoto T; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • McGovern DPB; Division of Gastroenterology, Department of Internal Medicine, Iwate Medical University, Morioka, Japan.
  • Nagasaki M; F. Widjaja Family Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
  • Kinouchi Y; Tohoku Medical Megabank Organisation, Tohoku University, Sendai, Japan.
  • Shimosegawa T; Health Administration Centre, Centre for the Advancement of Higher Education, Tohoku University, Sendai, Japan.
  • Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
J Crohns Colitis ; 13(5): 648-658, 2019 Apr 26.
Article in En | MEDLINE | ID: mdl-30500874
ABSTRACT
BACKGROUND AND

AIMS:

Genome-wide association studies [GWASs] of European populations have identified numerous susceptibility loci for Crohn's disease [CD]. Susceptibility genes differ by ethnicity, however, so GWASs specific for Asian populations are required. This study aimed to clarify the Japanese-specific genetic background for CD by a GWAS using the Japonica array [JPA] and subsequent imputation with the 1KJPN reference panel.

METHODS:

Two independent Japanese case/control sets (Tohoku region [379 CD patients, 1621 controls] and Kyushu region [334 CD patients, 462 controls]) were included. GWASs were performed separately for each population, followed by a meta-analysis. Two additional replication sets [254 + 516 CD patients and 287 + 565 controls] were analysed for top hit single nucleotide polymorphisms [SNPs] from novel genomic regions.

RESULTS:

Genotype data of 4 335 144 SNPs from 713 Japanese CD patients and 2083 controls were analysed. SNPs located in TNFSF15 (rs78898421, Pmeta = 2.59 × 10-26, odds ratio [OR] = 2.10), HLA-DQB1 [rs184950714, pmeta = 3.56 × 10-19, OR = 2.05], ZNF365, and 4p14 loci were significantly associated with CD in Japanese individuals. Replication analyses were performed for four novel candidate loci [p <1 × 10-6], and rs488200 located upstream of RAP1A was significantly associated with CD [pcombined = 4.36 × 10-8, OR = 1.31]. Transcriptome analysis of CD4+ effector memory T cells from lamina propria mononuclear cells of CD patients revealed a significant association of rs488200 with RAP1A expression.

CONCLUSIONS:

RAP1A is a novel susceptibility locus for CD in the Japanese population.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Crohn Disease / Genetic Predisposition to Disease / Rap1 GTP-Binding Proteins Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Crohn Disease / Genetic Predisposition to Disease / Rap1 GTP-Binding Proteins Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Year: 2019 Type: Article